This page lists ClinicalTrials.gov records that name Mazdutide among their listed interventions. Titles, phases, and status are taken from the official registry. It is a research reference only. It is not medical advice, and it does not offer or recommend any product for human or veterinary use.
Search
Compound
All compounds
Mazdutide
Phase
All phases
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Observational
Not applicable
Expanded access
Status
All statuses
No registered studies match that search or filter.
Not yet recruiting Not applicable Mazdutide
NCT ID NCT07803705
Sponsor Tongji Hospital
Registry dates 2026-11-15 – 2028-12-30
Enrollment 194 registered participants
Locations China
Conditions listed Fatty Pancreas; Overweight; Obesity Registry record on ClinicalTrials.gov
Recruiting Phase 4 Mazdutide
NCT ID NCT07775846
Sponsor Huijie Zhang
Registry dates 2026-11-03 – 2029-06-30
Enrollment 820 registered participants
Locations China
Conditions listed Type 2 Diabetic Kidney Disease Registry record on ClinicalTrials.gov
Not yet recruiting Phase 2 Mazdutide
NCT ID NCT07781150
Sponsor Tongji Hospital
Registry dates 2026-11-01 – 2031-06-30
Enrollment 128 registered participants
Locations China
Conditions listed Obesity; Overweight; Atypical Endometrial Hyperplasia; Endometrial Carcinoma Stage I +1 more Registry record on ClinicalTrials.gov
Not yet recruiting Phase 2 Mazdutide
NCT ID NCT07843862
Sponsor Fujian Shengdi Pharmaceutical Co., Ltd.
Registry dates 2026-10 – 2027-07
Enrollment 240 registered participants
Locations China
Conditions listed Type 2 Diabetes Registry record on ClinicalTrials.gov
Not yet recruiting Not applicable Mazdutide
NCT ID NCT07767552
Sponsor Yanbing Li
Registry dates 2026-09-30 – 2029-06-30
Enrollment 249 registered participants
Locations China
Conditions listed Diabetes Mellitus, Type 2 Registry record on ClinicalTrials.gov
Not yet recruiting Not applicable Mazdutide Semaglutide
NCT ID NCT07713992
Sponsor Tianjin Medical University
Registry dates 2026-09-15 – 2028-02-01
Enrollment 72 registered participants
Conditions listed Type 2 Diabetes Mellitus (T2DM); Nonalcoholic Fatty Liver Disease (NAFLD) With History of Diabetes Melitus Registry record on ClinicalTrials.gov
Not yet recruiting Phase 4 Mazdutide
NCT ID NCT07824895
Sponsor Hongwei Jiang
Registry dates 2026-09-15 – 2028-03-31
Enrollment 30 registered participants
Conditions listed Gout; Obesity (BMI>30); Hyperuricemia; Metabolic Syndrome Registry record on ClinicalTrials.gov
Recruiting Phase 4 Mazdutide
NCT ID NCT07657676
Sponsor China National Center for Cardiovascular Diseases
Registry dates 2026-09-14 – 2027-12-31
Enrollment 116 registered participants
Locations China
Conditions listed Obesity & Overweight; Coronary Heart Disease Registry record on ClinicalTrials.gov
Recruiting Phase 4 Mazdutide
NCT ID NCT07718126
Sponsor West China Hospital
Registry dates 2026-09-01 – 2029-08-31
Enrollment 60 registered participants
Locations China
Conditions listed Metabolic Dysfunction-Associated Steatohepatitis; Hepatic Steatosis; Living Liver Donors Registry record on ClinicalTrials.gov
Not yet recruiting Not applicable Mazdutide
NCT ID NCT07797101
Sponsor The Second Affiliated Hospital of Chongqing Medical University
Registry dates 2026-09-01 – 2029-05-31
Enrollment 50 registered participants
Conditions listed Cirrhosis; Portal Hypertension; Fatty Liver Disease; GLP-1 Registry record on ClinicalTrials.gov
Not yet recruiting Phase 4 Mazdutide
NCT ID NCT07654062
Sponsor Shandong Provincial Hospital
Registry dates 2026-07 – 2029-07
Enrollment 150 registered participants
Locations China
Conditions listed Prediabetes; Impaired Fasting Glucose; Impaired Glucose Tolerance (Prediabetes) Registry record on ClinicalTrials.gov
Recruiting Not applicable Mazdutide
NCT ID NCT07517042
Sponsor Shanghai Zhongshan Hospital
Registry dates 2026-06-10 – 2028-12
Enrollment 420 registered participants
Locations China
Conditions listed Obesity; Weight Control Registry record on ClinicalTrials.gov
Recruiting Not applicable Mazdutide Tirzepatide
NCT ID NCT07633639
Sponsor China-Japan Friendship Hospital
Registry dates 2026-05-01 – 2028-05-01
Enrollment 200 registered participants
Locations China
Conditions listed Obesity Registry record on ClinicalTrials.gov
Recruiting Phase 3 Mazdutide
NCT ID NCT07469800
Sponsor Innovent Biologics (Suzhou) Co. Ltd.
Registry dates 2026-04-23 – 2027-04-15
Enrollment 336 registered participants
Locations China
Conditions listed Overweight; Obesity; Hypertensive Registry record on ClinicalTrials.gov
Not yet recruiting Phase 3 Mazdutide
NCT ID NCT07417306
Sponsor Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Registry dates 2026-03-27 – 2027-12-31
Enrollment 912 registered participants
Locations China
Conditions listed Type 2 Diabetes Registry record on ClinicalTrials.gov
Recruiting Phase 3 Mazdutide
NCT ID NCT07255209
Sponsor Innovent Biologics (Suzhou) Co. Ltd.
Registry dates 2025-12-29 – 2028-10-31
Enrollment 180 registered participants
Locations China
Conditions listed Adolescents With Obesity or Overweight With Weight-Related Comorbidities Registry record on ClinicalTrials.gov
Not yet recruiting Not applicable Mazdutide
NCT ID NCT07135141
Sponsor Beijing Friendship Hospital
Registry dates 2025-09-30 – 2029-09-30
Enrollment 256 registered participants
Locations China
Conditions listed Severe Obesity Registry record on ClinicalTrials.gov
Recruiting Phase 3 Mazdutide
NCT ID NCT07083154
Sponsor The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Registry dates 2025-09-27 – 2029-08-01
Enrollment 420 registered participants
Locations China
Conditions listed Dementia, Mild; Mild Cognitive Impairment; Type 2 Diabetes Registry record on ClinicalTrials.gov
Active, not recruiting Phase 2 Mazdutide
NCT ID NCT06937749
Sponsor Innovent Biologics (Suzhou) Co. Ltd.
Registry dates 2025-06-20 – 2027-07-22
Enrollment 181 registered participants
Locations China
Conditions listed Metabolic Dysfunction-associated Steatohepatitis (MASH) Registry record on ClinicalTrials.gov
Active, not recruiting Phase 1, Phase 2 Mazdutide Tirzepatide
NCT ID NCT07000955
Sponsor Innovent Biologics (Suzhou) Co. Ltd.
Registry dates 2025-06-17 – 2027-05-14
Enrollment 98 registered participants
Locations China
Conditions listed Obesity Registry record on ClinicalTrials.gov
Recruiting Phase 3 Mazdutide
NCT ID NCT06931028
Sponsor Innovent Biologics (Suzhou) Co. Ltd.
Registry dates 2025-06-12 – 2027-06-11
Enrollment 260 registered participants
Locations China
Conditions listed Sleep Apnea; Obstructive; Obesity Registry record on ClinicalTrials.gov
Active, not recruiting Phase 3 Mazdutide
NCT ID NCT06884293
Sponsor Innovent Biologics (Suzhou) Co. Ltd.
Registry dates 2025-05-09 – 2027-06-30
Enrollment 479 registered participants
Locations China
Conditions listed Overweight; Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) Registry record on ClinicalTrials.gov
Active, not recruiting Phase 2 Mazdutide
NCT ID NCT06862908
Sponsor Innovent Biologics (Suzhou) Co. Ltd.
Registry dates 2025-03-26 – 2027-02-11
Enrollment 141 registered participants
Locations China
Conditions listed Obesity; Heart Failure With Preserved Ejection Fraction (HFPEF); Heart Failure With Mildly Reduced Ejection Fraction Registry record on ClinicalTrials.gov
Completed Phase 2 Mazdutide
NCT ID NCT06817356
Sponsor Eli Lilly and Company
Registry dates 2025-02-06 – 2026-05-19
Enrollment 308 registered participants
Locations United States
Conditions listed Alcohol Use Disorder Registry record on ClinicalTrials.gov
Completed Phase 1, Phase 2 Mazdutide
NCT ID NCT06519656
Sponsor Shanghai Zhongshan Hospital
Registry dates 2024-10-21 – 2026-09-18
Enrollment 43 registered participants
Locations China
Conditions listed Polycystic Ovary Syndrome Registry record on ClinicalTrials.gov